Interventions for prostate cancer survivorship: A systematic review of reviews

Document Type

Journal Article

Publication Title

Psycho‐Oncology

ISSN

1099-1611

Volume

27

Issue

10

First Page

2339

Last Page

2348

PubMed ID

30255558

Publisher

John Wiley and Sons Ltd

School

School of Medical and Health Sciences / Centre for Exercise and Sports Science Research

RAS ID

28003

Comments

Crawford‐Williams, F., March, S., Goodwin, B. C., Ralph, N., Galvão, D. A., Newton, R. U., ... & Dunn, J. (2018). Interventions for prostate cancer survivorship: A systematic review of reviews. Psycho‐Oncology. 27(10) 2339 - 2348. Available here

Abstract

OBJECTIVE: To systematically review the evidence for interventions addressing key domains of the American Cancer Society (ACS) and American Society of Clinical Oncology (ASCO) Prostate Cancer Survivorship Care Guidelines: health promotion, surveillance, physical side effects, psychosocial management, and care coordination.

METHODS: We conducted a systematic review of systematic reviews and meta-analyses of interventions targeting ACS/ASCO guideline domains. All titles and abstracts were independently assessed for inclusion based on predetermined criteria. Relevant data were extracted, and assessment of methodological quality was performed.

RESULTS: Forty-four systematic reviews of interventions targeting ACS prostate cancer guideline domains were included for review. Exercise and psychosocial interventions were effective for improving men's survivorship outcomes in the domains of health promotion, physical side effects, and psychosocial management. Across the domains, evidence quality varied and there was a limited diversity of participants. No reviews of interventions addressing surveillance and cancer care coordination were identified.

CONCLUSIONS: There are substantive knowledge gaps in prostate cancer survivorship research that are a barrier to real improvements in men's outcomes across the breadth of the survivorship experience. A targeted research and implementation agenda in prostate cancer survivorship is urgently needed if we are to meet the current and future burden of this disease on individuals, families, and communities.

DOI

10.1002/pon.4888

Access Rights

subscription content

Share

 
COinS